ARROW recallZ-0351-2023 · ARROW INTERNATIONAL Inc. · initiated Oct 27, 2022
Terminated
Is my device affected?
- Compare the model, catalog and lot or serial numbers on your device or its packaging with the code information below. A recall usually covers only specific models or lots.
- If yours is listed, follow the instructions from ARROW INTERNATIONAL Inc. or your healthcare provider. The company's action is summarized under what the company is doing.
- Do not stop using a prescribed or implanted device on your own — talk to your healthcare provider first.
Where to find your model and lot numbers · What recall classes and statuses mean
Why it was recalled
There is the potential for inadequate connection between the top and bottom housings of the Micro Clave Clear Connectors included in the Arrow MAC Two-Lumen Central Venous Access Kit and the Arrow Pressure Injectable Arrowg+ard Blue Plus Three-Lumen CVC Kit.
FDA root cause category: Process design
What the company is doing
The firm issued an "URGENT MEDICAL DEVICE RECALL" to its consignees on 10/27/2022 by FedEx 2-day mail. The notice explained the problem, the risk, and requested the following: "Action list number 1 Medical facilities 1. Immediately check your inventory for product within the scope of this recall. Users should cease use and distribution of affected product and immediately quarantine the affected product. 2. If you have affected product, complete the RECALL ACKNOWLEDGEMENT FORM, Contact Teleflex Customer Service to receive a return goods authorization (RGA) number. 3. Complete and return form even if you do not have affected product. 4. Teleflex (or your local dealer) will issue a credit note upon receipt of the returned affected product. Action list number 2 Distributors 1. Provide this recall notice to all customers who have received affected product. Each customer is then required to complete the Acknowledgement Form (Appendix 1) and return it to you. 2. Immediately check your inventory for affected product. Cease use and distribution of affected product and immediately quarantine the affected product. You may then return all product in scope. 3. Confirm to Teleflex that you have completed the field activity outlined in actions 1 and 2 of this Action List Number 2. Upon completion of your actions, please forward the completed Acknowledgement Form to Teleflex Customer Service at the contact details provided below. Important - Please ensure you only list lot numbers in scope of this recall notice when completing the Acknowledgement Form (Appendix 1). 4. If you have further distributed product outside of your country, please notify Teleflex Customer Service by return email to the email address provided below. Customer Service via Email: [email protected], Customer Service Telephone: 1-866-396-2111, or FAX: 1-855-419-8507. Customer Service hours of operation are 8am-7pm EST.
Recall details
- Recall number
- Z-0351-2023
- Status
- Terminated
- Initiated by the company
- Oct 27, 2022
- Posted by the FDA
- Dec 10, 2022
- Recalling firm
- ARROW INTERNATIONAL Inc.
- Quantity
- 80 units
- Product code
- FOZ
- FDA submissions
- K071538, K002507
- Distribution
- US Distributor in states of: FL, GA, KY, OH, PA and WV.
Product description
Arrow MAC Two-Lumen Central Venous Access Kit fr use with 7 - 7.5 Fr Catheters, REF ASK-11242-UPM1; catheter introducer
Code information (models, lots, serial numbers)
UDI/DI 10801902159448, Lot Number 13F22C0349
Devices named in this recall
1 device in the FDA device registry whose identifier appears in the recall's code information.
- ARROW IPN055805Teleflex Incorporated · Catheter, intravascular, therapeutic, short-term less than 30 days1 recall0 reports
Product lines
Other devices under the same FDA submission
246 devices cleared under K071538, K002507 are not named by identifier in this recall. One submission often covers many models, so they may or may not be affected.
- ARROW IPN038522Teleflex Incorporated · Catheter, intravascular, therapeutic, short-term less than 30 days3 recalls1 report
- ARROW IPN931283Teleflex Incorporated · Catheter, intravascular, therapeutic, short-term less than 30 days3 recalls0 reports
- ARROW IPN931284Teleflex Incorporated · Catheter, intravascular, therapeutic, short-term less than 30 days3 recalls0 reports
- ARROW IPN931286Teleflex Incorporated · Catheter, intravascular, therapeutic, short-term less than 30 days3 recalls0 reports
- ARROW IPN036445Teleflex Incorporated · Catheter,intravascular,therapeutic,short-term less than 30 days2 recalls8 reports
- ARROW IPN915628Teleflex Incorporated · Catheter, intravascular, therapeutic, short-term less than 30 days2 recalls5 reports
- ARROW IPN915630Teleflex Incorporated · Catheter, intravascular, therapeutic, short-term less than 30 days2 recalls2 reports
- ARROW IPN036474Teleflex Incorporated · Catheter,intravascular,therapeutic,short-term less than 30 days2 recalls1 report
- ARROW IPN904896Teleflex Incorporated · Catheter,intravascular,therapeutic,short-term less than 30 days2 recalls1 report
- ARROW IPN038523Teleflex Incorporated · Catheter, intravascular, therapeutic, short-term less than 30 days2 recalls1 report
- ARROW IPN055818Teleflex Incorporated · Catheter, intravascular, therapeutic, short-term less than 30 days2 recalls1 report
- ARROW IPN055820Teleflex Incorporated · Catheter, intravascular, therapeutic, short-term less than 30 days2 recalls1 report
Other products in the same recall event
The FDA groups related products into one recall event (event 91090).
- Z-0352-2023 · TerminatedPressure Injectable Arrowg+ard Blue Plus Three-Lumen CVC Kit, REF numbers: a) ASK-42703-NS, b) ASK-42703-PCCH2, c) ASK-42703-PUPM1, d) ASK-45703-NS, e) ASK-45703-PAU, f) ASK-45703-…
Sources and updates
- Recall record: FDA Medical Device Recalls, file dated Oct 16, 2026 · View the FDA recall notice ↗
- Devices: FDA GUDID, file dated Oct 13, 2026. Devices are linked when their identifier (with a valid check digit) appears in the recall's code information.
- Page last rebuilt: Oct 16, 2026. Text above is shown as published by the FDA.
How recalls are matched to devices · Editorial policy · Report an error on this page